Imbalance of endocannabinoid/lysophosphatidylinositol receptors marks the severity of alzheimer’s disease in a preclinical model: A therapeutic opportunity

  1. Medina-Vera, D.
  2. Rosell-Valle, C.
  3. López-Gambero, A.J.
  4. Navarro, J.A.
  5. Zambrana-Infantes, E.N.
  6. Rivera, P.
  7. Santín, L.J.
  8. Suarez, J.
  9. de Fonseca, F.R.
Aldizkaria:
Biology

ISSN: 2079-7737

Argitalpen urtea: 2020

Alea: 9

Zenbakia: 11

Orrialdeak: 1-22

Mota: Artikulua

DOI: 10.3390/BIOLOGY9110377 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus